Back to calendar
ImmunityBio, Inc. (IBRX) Earnings
IBRX reports earnings on Tuesday, August 4, 2026
earnings report
August 4, 2026
Q2 2026
Est. EPS: $-0.07
Actual EPS: $-0.22
EPS surprise: -175.00%
Company overview
Market Cap$8.1B
PriceUSD 7.64
EPS (TTM)-0.94
52-week high12.43
52-week low1.95
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees691